1st Quarter - Amendment
BROWN RUDNICK LLP for HOSPIRA, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S. Con. Res. 8 - provisions relating to ACA medical device tax. H.R. 933- Consolidated and Further Continuing Appopriations Act relating to FDA biosimilar user fees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Health Issues HCR
P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. Issues relating to generic drug labeling and drug pedigree.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.